Abstract:Background The effects of seasonal influenza vaccination on cardiovascular disease (CVD) outcomes, including among individuals with established CVD, are uncertain. Methods To evaluate the efficacy and safety of influenza vaccines compared to no vaccines or placebo for preventing all-cause/CVD mortality or all-cause/CVD hospitalization in the general population and in populations with pre-existing CVD, we conducted a living systematic review (LSR) and prospective meta-analysis (PMA). Published randomized controlled trials (RCT) and observational studies between 1994 and 2023 were searched. PRISMA guidelines were followed in the extraction of study details, and risk of bias was assessed using the Cochrane tools. Analyses were stratified by study design and CVD history. Study quality was evaluated using GRADE system. Meta analyses based on random-effects models were performed between July and October 2022. Pooled risk ratios (RRs) for all-cause/CVD mortality and all-cause/CVD hospitalization were main outcomes. Results Six published RCTs comprising 12,662 participants (mean age, 62 years; 45 % women; 8,797 with pre-existing CVD) and 37 observational studies comprising 6,311,703 participants (mean age, 49 years; 50 % women; 1,189,955 with pre-existing CVD) were included. Only those RCTs judged to be low risk were included in the analyses, and observational studies at anything greater than moderate risk of bias were excluded. In RCTs, influenza vaccine was not significantly associated with lower all-cause mortality (RR, 0.85; 95 %CI, 0.61–1.17), cardiovascular death (RR, 0.80; 95 %CI, 0.60–1.07), or CVD hospitalization (RR, 0.69; 95 %CI, 0.47–1.02). A statistically significant reduction in all-cause hospitalization (RR, 0.86; 95 %CI, 0.76–0.97) was observed. The evidence level was assessed as moderate for all-cause hospitalization, and low for other outcomes. Overall, observational studies suggested a stronger protective association between influenza vaccination and outcomes, except for CVD hospitalization. Based on RCTs, there was no difference in the effects of influenza vaccination on all-cause mortality among the general population compared to those with pre-existing CVD, although the summary point estimate favored benefits only in those with pre-existing CVD. Conclusions While observational studies suggest that influenza vaccination may be associated with lower all-cause and CVD mortality and all-cause hospitalization, RCTs reported to date suggest a reduction in the risk of all-cause hospitalization but do not provide clear evidence to support preventive effects on mortality (all-cause or CVD) or CVD hospitalization.

Repeated influenza vaccination and hospitalization outcomes among older patients with cardiovascular or respiratory diseases

Influenza Vaccination And Hospitalization Outcomes Among Older Patients With Cardiovascular Or Respiratory Diseases

Effectiveness of Influenza Vaccination on In-Hospital Death and Recurrent Hospitalization in Older Adults with Cardiovascular Diseases.

Effectiveness of Influenza Vaccination on In-Hospital Death in Older Adults with Respiratory Diseases.

The Effectiveness of Influenza Vaccine among Elderly Chinese: A Regression Discontinuity Design Based on Yinzhou Regional Health Information Platform

The Effectiveness of Influenza Vaccination in Preventing Hospitalizations in Elderly in Beijing, 2016-18

Effectiveness of Influenza Vaccination on Hospitalization Outcomes among Older Patients with Diabetes

Influenza-associated cardiovascular mortality in older adults in Beijing, China: a population-based time-series study

Trend Analysis of Influenza Vaccination among Hospitalized Elderly People in Beijing,2013-2019

The association between influenza vaccination, cardiovascular mortality and hospitalization: A living systematic review and prospective meta-analysis

Effectiveness of influenza vaccines in preventing acute cardiovascular events within 1 year in Beijing, China

Influenza Vaccination and the Risk of Ventricular Arrhythmias in Patients With Chronic Obstructive Pulmonary Disease: A Population-Based Longitudinal Study

Association between influenza vaccination and one‐year all‐cause and cardiovascular mortality risk: A self‐controlled case series and matched case‐control study

Influenza Vaccine Effectiveness Pre-pandemic Among Adults Hospitalized With Congestive Heart Failure or Chronic Obstructive Pulmonary Disease and Older Adults

Influenza Vaccine Effectiveness in Preventing Hospitalization among Beijing Residents in China, 2013-15.

Protective Impact of Influenza Vaccination on Healthcare Workers

Effects of influenza vaccination on clinical outcomes of chronic obstructive pulmonary disease: A systematic review and meta-analysis

Dual Influenza and Pneumococcal Vaccination Was Associated with Lower Short-Term Risks of All-Cause and Acute Respiratory Hospitalizations among the Elderly in Shenzhen, China: a Retrospective Cohort Study.

Incidence, symptoms and medical care for influenza virus and respiratory syncytial virus illnesses among older adults in Eastern China: Findings from the China Ageing Respiratory Infections Study (CARES), 2015-2017

Protective Effects from Prior Pneumococcal Vaccination in Patients with Chronic Airway Diseases during Hospitalization for Influenza—A Territory-Wide Study

Relative effectiveness of influenza vaccines in elderly persons in the United States, 2012/2013-2017/2018 seasons